Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.48 |
| ▸ | MMP8 | P22894 | 1/20 | 0.48 |
| ▸ | MASP2 | O00187 | 2/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.41 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CTSC | P53634 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20117423 | 0.86 | MMP8 (0.51) | SPHK1MMP8MASP2F2ALDH1A1 | |
| SCHEMBL14628026 | 0.81 | MMP8 (0.56) | SPHK1MMP8MASP2F2ALDH1A1 | |
| SCHEMBL13418073 | 0.80 | MMP8 (0.55) | SPHK1MMP8MASP2F2ALDH1A1 | |
| SCHEMBL21582601 | 0.79 | ALDH1A1 (0.60) | SPHK1MMP8ALDH1A1KMT2AMEN1 | |
| SCHEMBL12445594 | 0.78 | LNPEP (0.61) | SPHK1MMP8MASP2F2ALDH1A1 | |
| SCHEMBL17366111 | 0.77 | MMP8 (0.51) | SPHK1MMP8MASP2F2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL27450409 | 0.76 | F2 (0.67) | SPHK1MMP8MASP2F2 | |
| SCHEMBL8549002 | 0.75 | SPHK1 (0.57) | SPHK1MMP8KMT2A | |
| SCHEMBL23793953 | 0.74 | TPSAB1 (0.55) | SPHK1MMP8MASP2F2ALDH1A1 | |
| SCHEMBL5018826 | 0.74 | SCN9A (0.57) | SPHK1MMP8MASP2F2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170145054-A1 | PROCESS FOR THE PRODUCTION OF A DIPEPTIDE DERIVATIVE | DSM IP ASSETS B.V. (NL) | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170145054-A1 | PROCESS FOR THE PRODUCTION OF A DIPEPTIDE DERIVATIVE | VIP, PEPD, DNPEP | SPHK1 1545/4885MMP8 3300/4885MASP2 927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.